Summit Therapeutics (SMMT) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order with introductions of executive team, board members, and external counsel.

• Notice of meeting and proxy materials were mailed to all stockholders on or about April 17, 2026.

• Four matters were set for voting: election of directors, ratification of auditors, executive compensation, and amendment to the stock incentive plan.

Board and executive committee updates

• Board nominees for terms expiring in 2027 were presented, including current executives and independent directors.

Shareholder proposals

• Ratification of PricewaterhouseCoopers LLP as independent auditors for 2026.

• Advisory vote on executive compensation.

• Amendment to the 2020 Stock Incentive Plan to increase shares by eight million.